BackBone Biologics Overview

Bone Biologics Receivables

Bone Biologics's receivables is $7K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6986.00

Peer trimmed avg / median

Loading

Bone Biologics Receivables History

Loading

Bone Biologics vs. peers: Receivables Comparison

Loading

Bone Biologics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bone Biologics (BBLG) FAQ

Bone Biologics (BBLG) currently reports a receivables of $7K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bone Biologics's receivables history and peer comparisons.

Bone Biologics's receivables changed from $0 to $7K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bone Biologics reported $7K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $7K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bone Biologics, and consider following BBLG for alerts when major investors trade the stock.